Oesophageal Carcinoma Recruiting Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02111850T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 PositiveTreatment